XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 11,104 $ 6,655 $ 32,190 $ 21,174
General and administrative 12,989 1,631 34,211 5,157
Sales and marketing 1,082 266 2,717 825
Total operating expenses 25,175 8,552 69,118 27,156
Loss from operations (25,175) (8,552) (69,118) (27,156)
Interest expense 0 (4) (5) (5)
Dividend income 739 2 741 95
Change in fair value of warrant liabilities 6,975 0 3,442 0
Other (expense), net (630) (3) (627) (2)
Loss before provision for income taxes (18,091) (8,557) (65,567) (27,068)
Provision for income taxes 0 0 0 0
Net loss (18,091) (8,557) (65,567) (27,068)
Comprehensive loss $ (18,091) $ (8,557) $ (65,567) $ (27,068)
Net loss per common share attributable to common stockholders, basic (in dollars per share) $ (0.13) $ (1.60) $ (1.09) $ (5.06)
Net loss per common share attributable to common stockholders, diluted (in dollars per share) $ (0.13) $ (1.60) $ (1.09) $ (5.06)
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares) 136,456,848 5,360,497 60,104,891 5,350,771
Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in shares) 136,456,848 5,360,497 60,104,891 5,350,771